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Abstract
Background: Diarrhoeagenic Escherichia coli (DEC) pathotypes are among the most common bacterial causes of
morbidity and mortality in young children. These pathogens are not sought routinely and capacity for their detection is
limited in Africa. We investigated the distribution and dissemination of DEC in 126 children paired with their mothers
in a Nigerian community.
Methods: A total of 861 E. coli were isolated from 126 children with diarrhoea and their mothers. Antimicrobial
susceptibility of each isolate was determined by Kirby-Bauer disc diffusion technique. All the isolates were
screened for DEC markers by multiplex PCR. Genetic relatedness of DEC strains was determined by flagellin
typing and Insertion element 3 (IS3)-based PCR.
Results: DEC were identified from 35.7 % of individuals with the most common pathotype being shiga toxin-producing
E. coli (42, 16.7 %). Identical pathotypes were found in 13 (10.3 %) of the mother-child pairs and in three of these strains
from mothers and their children showed identical genetic signatures. Over 90 % of DEC isolates were resistant to
ampicillin, sulphonamide, tetracycline, streptomycin or trimethoprim, but only 9 (7.2 %) were ciprofloxacin resistant
Conclusion: The data suggest that healthy mothers are asymptomatic reservoirs of multiply-resistant strains that are
pathogenic in their children and there are instances in which identical strains are found in mother-child pairs.
Keywords: Diarrhoea, Diarrhoeagenic Escherichia coli, Mother-child pairs, Antimicrobial resistance
Background
Each year, diarrhoeal disease is responsible for deaths of
one in every ten children less than 5 years, resulting in
750,000 fatalities worldwide especially in sub-Saharan
Africa and south Asia [1, 2]. In some parts of these re-
gions, mortality rates are reducing considerably by about
4 % every year due to improved hygiene practices and
the success of oral rehydration therapy. Morbidity due
to diarrhoea is still however high in many other coun-
tries where outbreaks of diarrhoeal diseases continue to
affect many infants and young children [1, 3, 4]. Thus,
understanding the epidemiology and transmission of the
disease is important to accelerating the decline in mor-
tality and morbidity.
Thirty to forty percent of cases of acute diarrhoea in
children below 5 years of age are caused by diarrhoeagenic
Escherichia coli (DEC) [5–7]. Six pathotypes of DEC are
recognized on the basis of specific virulence factors. These
are enterotoxigenic E. coli (ETEC), enteroinvasive E. coli
(EIEC), enteropathogenic E. coli (EPEC), enterohemorrha-
gic E. coli (EHEC) (including shiga toxin producing E. coli
(STEC)), enteroaggregative E. coli (EAEC), and diffusely
adherent E. coli (DAEC) [8]. The epidemiological sig-
nificance and prevalence of each category of DEC in
childhood diarrhoea varies from one geographical loca-
tion to another. In spite of these variations, very few
studies with discriminatory methodology have been car-
ried out in sub-Saharan Africa to investigate the burden
of the pathogens [7–12].
Diarrhoea is spread primarily through faecal-oral route,
especially when contaminated food or water is consumed,
though evidence also showed that secondary transmission
or person-to-person transmission of diarrhoeal pathogens
also occurs, particularly among members of the same
household. If sharing of strains within the same household
contributes significantly to the perpetuation of virulent
clones, efforts to prevent within-household transmission
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could truncate the spread of diarrhoeagenic E. coli clones
in the community, in addition to protecting vulnerable
children from infection [13, 14].
We sought to evaluate the occurrence of DEC in chil-
dren with diarrhoea as well as the role of close contact
in intra-familial co-occurrence of DEC by comparing
DEC recovery from these children and their mothers in
a Nigerian community.
Methods
Study population and sample collection
Approval (IEC No. 00005422) for the study was obtained
from the Ethics and Research committee of Obafemi
Awolowo University Teaching Hospitals Complex, Ile-
Ife. Participants were recruited at the State Hospital
Oke-Ogbo, Ile-Ife, Osun State, between February 2008
and February 2011. All the participants gave informed
consent. One hundred and twenty-six children aged
five and below with diarrhoea of not more than 2
weeks duration, paired with their mothers (i.e. 252 in-
dividuals), were included. Consenting mothers and
their children were requested to produce stool samples
in sterile universal bottles. All samples were trans-
ported within 2 hours of collection to the laboratory
for processing.
Detection and Identification of Escherichia coli strains
Faecal samples were inoculated onto Eosin Methylene
Blue (EMB) agar plates (Oxoid Ltd., Basingstoke,
Hampshire, England) and incubated for 24 h aerobically
at 37 °C. Up to five morphologically distinct colonies
typical of E. coli were picked and identified by standard
biochemical testing [15].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing for the isolates was
performed by the Kirby-Bauer disc diffusion technique
on Mueller Hinton agar (CM0337) (Oxoid Ltd., Basing-
stoke, Hampshire, England). Antibiotics tested included
ampicillin (AMP) (l0μg), streptomycin (STREP) (l0μg),
ciprofloxacin (CIP) (5 μg), nalixidic acid (NAL) (30 μg),
tetracycline (TET) (30 μg), chloramphenicol (CHLO)
(30 μg), sulphonamide (SUL) (300 μg), and trimethoprim
(TRIM) (5 μg) (Remel, U.S.A). The inoculated plates
were incubated at 37 °C for 24 h. Interpretation of the
diameters of the zones of inhibition was done according
to the guidelines set by clinical laboratory and standard
institute (2008). E. coli ATCC 25922 was used as the
quality control strain.
DNA Extraction
Isolate stocks were produced by sub-culturing single col-
onies from primary isolation plates. Two to three colonies
of the isolates were grown overnight in 5 ml of peptone
broth (Oxoid). A 1 ml aliquot of the culture was centri-
fuged at 10,000 rpm for 2 min in a microcentrifuge
(Biorad, USA). The cell pellet was suspended in 100 μl of
sterile water and boiled for 10 min. The resulting DNA
suspension was used as template DNA in subsequent
polymerase chain reaction (PCR) amplifications.
Screening for Diarrhoeagenic E. coli
E. coli isolates were screened for virulence genes that
characterized five different pathotypes of diarrhoeagenic
E. coli namely ETEC, EIEC, EPEC, EAEC, and EHEC in-
cluding STEC by multiplex PCR [16] (Table 1). E. coli
strains E2348/69, 042, H10407, EDL933, and E137
served as positive controls for EPEC, EAEC, ETEC,
EHEC (STEC), and EIEC respectively. E. coli DH5α,
which lacks all the diarrhoeagenic genes was used as a
negative control. Amplified reactions (5 μl) were electro-
phoresed on a 1.5 % (w/v) agarose gel in 1X TAE buffer
and visualized in ultraviolet light after ethidium bromide
staining.
Genetic profiling
Insertion element 3 (IS3)-based PCR profiles were gener-
ated by amplification with the IS3A primer of Thompson
et al. [17] (Table 1) and electrophoresis on 1.5 % agarose
gels as previously described [18]. PCR-Restriction frag-
ment length polymorphisms of the fliC gene were per-
formed by amplifying the fliC allele and digesting
amplicons with RsaI, as described by Fields et al. [19].
Each distinct PCR-RFLP profile was assigned a letter code.
Statistical analysis
The Chi square (χ2) and Fischer’s exact test (two tailed),
performed using SPSS statistical software (version 15)
(Chicago, IL, USA) were used to determine the statistical
significance of the data. All reported p-values were two-
sided and a p-value of less than or equal to 0.05 was
considered to be statistically significant.
Results
Subjects and Faecal Escherichia coli isolates
A total of 252 stool samples were collected from 126
children with diarrhoea aged one month to five years
(13.57 ± 11.35) paired with their apparently healthy
mothers aged 15 to 46 years (19.74 ± 10.88). The chil-
dren were distributed as: 0–6 months 25 (19.8 %), 7–12
months 57 (45.2 %), 13–24 months 33 (26.2 %), and
25–60 months 11 (8.7 %). From the 252 samples exam-
ined, 861 strains of E. coli comprising of 438 from chil-
dren and 423 from mothers were isolated.
Diarrhoeagenic Escherichia coli pathotypes
Of 252 stool samples examined, 90 (35.7 %), comprised
of 45 samples from mothers and 45 from children were
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positive for at least one pathotype of DEC. In all, there
were 125 different DEC strains identified of which 65
(25 %) and 60 (48 %) were from children and mothers
respectively (Table 2). Shiga toxin producing E. coli
(STEC) 42 (16.7 %) was the most prevalent sub-pathotype
of DEC detected. Thirty-two of these STEC strains har-
bored both stx1 and stx2 genes. Other pathotypes identi-
fied were enterotoxigenic E coli (ETEC) 40 (15.9 %),
enteroaggregative E. coli 21 (8.3 %), and enteropathogenic
E. coli (EPEC) 13 (5.2 %). Enteroinvasive (EIEC) 2 (0.8 %)
were found only among isolates from mothers. Among
the ETEC strains, heat-labile toxin gene alone was more
commonly found, 23 (57.5 %) than the heat stable toxin
gene 16 (40 %), whereas only 1 of 40 (2.5 %) possessed
both genes.
Multiple DEC pathotypes were recovered from 8
(6.3 %) children and 10 (7.9 %) mothers. As shown in
Table 3, the most frequent of such combinations was
STEC with EPEC, 3 (16.7 %).
As shown in Table 4, DEC were most commonly
recovered from children aged between age 7 and
24 months. Recovery within the first 6-months of life
and after two years was relatively rare. STEC was iso-
lated across the different age categories, whereas EPEC
was most commonly seen in children less than 1 year.
Table 1 Polymerase chain reaction primers for diarrhoeagenic genes, IS3 and fliC of Escherichia colia
Target gene or probe Type Primer Designation Primers (5’ to 3’) Amplicon size (base pair)
eae EPEC/EHEC eae 1 CTGAACGGCGATTACGCGAA 917
eae 2 CCAGACGATACGATCCAG
bfp EPEC bfp 1 AATGGGCTTGCGCTTCCAG 326
bfp 2 GCCGCTTTATCCAACCTGGTA
CVD432 EAEC EAEC1 CTGGCGAAAGACTGTATCAT 630
EAEC2 CAATGTATAGAAATCCGCTGTT
LT gene ETEC LTf GGCGACAGATTATACCGTGC 450
LTr CGGTCTCTATTATACCGTGC
ST gene ETEC STf ATTTTTMTTTCTGTATTRTCTT 190
STr CACCCGGTACARGCAGGATT
ipaH EIEC IpaH1 GTTCCTTGACCGCCTTTCCGATACCGTC 600
IpaH2 GCCGGTCAGCCACCCTCTGAGAGTAC
Stx1 EHEC/STEC Stx1f ATAAATCGCCATTCGTTGACTAC 180
Stx2r AGAACGCCCACTGAGATCATCC
stx2 EHEC/STEC Stx2f GGCACTGTCTGAAACTGCTCC 255
Stx2r TCGCCAGTTATCTGACATTCTG
IS3 N/A IS3 ACACTTAGCCGCGTGTCC Variable
fliC N/A F-FLIC1 ATGGCACAAGTCATTAATACCCAAC Variable
R-FLIC2 CTAACCCTGCAGCAGAGACA
aeae intimin, EPEC Enteropathogenic E. coli, EHEC Enterohemorrhagic E. coli, bfp bundle forming pilus, CVD432 aggregative adherence plasmid marker, EAEC
Enteroaggregative E. coli, LT Heat-labile toxin, ETEC Enterotoxigenic E. coli, ST Heat-stable toxin, ipaH invasive plasmid antigen, EIEC Enteroinvasive E. coli, stx
shiga toxin, STEC shiga toxin producing E. coli, N/A Not applicable
Table 2 Distribution of diarrhoeagenic virulence genes in faecal
Escherichia coli from mother and child pairs*
No. (%) of subjects
DEC Type Mothers Children P-value (χ2)
(n = 126) (n = 126)
EAEC 11 (8.7) 10 (8.7) 1.000
STEC 18 (14.3) 24 (19) 0.310
stx1 (only) 6 (4.8) 4 (3.2) 0.749
stx2 (only) - - -
stx1and stx2 12 (9.5) 20 (15.9) 0.130
EPEC 7 (5.6) 7 (5.6) 0.776
Typical (bfp+) 7 (5.6) 3 (2.4) 0.334
Atypical (bfp-) 0 (0) 4 (3.2) 0.122
ETEC 20 (15.9) 20 (15.9) 1.000
LT (only) 9 (7.1) 14 (11.1) 0.274
ST (only) 10 (8.7) 6 (4.8) 0.310
LT and ST 1 (0.8) 0 (0) 1.000
EIEC 2 (1.6) 0 (0) 0.498
Total 60 (48) 65 (52) 0.527
*p-value Probability value of chi square, EAEC Enteroaggregative E. coli, EHEC
Enteroheamorrhagic E. coli, STEC Shiga toxin producing E. coli, stx shiga toxin,
EPEC Enteropathogenic E .coli, bfp bundle forming pilus, ETEC Enterotoxigenic
E. coli, LT Labile toxin, ST Stable toxin, EIEC Enteroinvasive E. coli
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The other pathotypes were most commonly recovered
from children 7–24 months.
Recovery of identical pathotypes of DEC from mother and
child pairs
Identical DEC pathotypes were detected in 13 (10.3 %)
of all the 126 mother-child pairs tested. These consisted
of five ETEC, five EAEC and three STEC strains. EAEC
was recovered in 2 (1.6 %) of children (with infected
mothers) in the age groups 7–12 months and 13–24
months while 1 (0.8 %) was recovered in age group 25–
60 months. No EAEC was detected in children below
7 months of age. Four of five pairs from which ETEC
was recovered included infected children in the age range
7–12 months. No EPEC and EHEC were recovered from
children with colonized mothers (Table 5).
We determined whether isolates of the same pathotype
obtained from mother-infant pairs produced identical or
similar band patterns after PCR profiling with an IS3
primer (Fig. 1). Isolates showing non-identical profiles
that were similar were shortlisted because in our experi-
ence, IS3 profiles can vary slightly between experiments.
Five within-pair similarities were seen: these strains
showed identical or similar (not more than two different
bands) profiles. Isolates showing within-pair similarities
were then subjected to fliC allele typing by PCR-RFLP.
Based on these profiles indistinguishable isolates were
obtained from five mother-infant pairs (Table 6). Three
isolates pairs showed identical/similar IS3 profiles and
identical fliC PCR-RFLP patterns. Two of these pairs
were EAEC (C16b and M16d, C271a and M271a) and
the third STEC isolates (C72b and M72a). Two ETEC
isolates showed similar/identical IS3 patterns and pro-
duced no fliC amplicons (Table 6). Within-pair IS3 pro-
files were distinctly different for seven pairs and in the
case of one ETEC pair, although the IS3 profiles were
identical, fliC PCR-RFLP patterns were different (Fig. 1,
Table 6). Thus we conclude that in the case of three to
five mother infant pairs, identical DEC isolates were re-
covered from mother and child. IS3 profiles (Fig. 1) and
fliC PCR-RFLP patterns (Fig. 2) differed considerably
among different pairs suggesting that a diverse range of
DEC strains are circulating in the study population.
Antimicrobial resistance patterns of diarrhoeagenic
Escherichia coli (DEC) isolates and Non Diarrhoeagenic
Escherichia coli (non-DEC) from mother and child pairs
The DEC (n = 125) isolates exhibited high rates of resist-
ance to most antibacterial commonly available and that
were also tested in the study. These included ampicillin
121 (96.8 %), sulphonamide 118 (94.4 %), tetracycline
119 (95.2 %), streptomycin 115 (92 %), trimethoprim 113
(90.4 %), chloramphenicol 58 (46.4 %), and nalidixic acid
58 (46.4 %). A much lower rate of resistance was seen to
ciprofloxacin 9 (7.2 %). Similar profiles were seen with
specific pathotypes detected. While all the EAEC (21 of
21), and EIEC (2 of 2) strains were resistant to tetracyc-
line, sulphonamide, ampicillin and streptomycin, they
were all susceptible to ciprofloxacin (Table 7).
When the antimicrobial resistance profiles of 125 diar-
rhoeagenic E. coli isolates were compared with that of the
736 non-DEC isolates, there was no significant difference
in the rates of resistance as both groups recorded similar
Table 3 Frequency of multiple pathotypes of diarrhoeagenic
Escherichia coli among the mother and child groupsa
Multiple pathotypes No (%) of positive samples
Mother (n = 126) Child (n = 126)
ETEC (ST) + STEC 1 (0.8) 1 (0.8)
ETEC (LT) + STEC 1 (0.8) 0 (0)
ETEC (ST) + ETEC (LT) 2 (0.8) 0 (0)
EPEC + ETEC(ST) 1 (0.8) 1 (0.8)
EPEC + ETEC(LT) + ETEC(ST) 0 (0) 1 (0.8)
EHEC + EPEC + ETEC(LT) + EAEC 0 (0) 1 (0.8)
EAEC + ETEC(LT + ST) 1 (0.8) 0 (0)
EAEC + ETEC(LT) 0 (0) 1 (0.8)
EAEC + ETEC(ST) + EIEC 1 (0.8) 0 (0)
EPEC + STEC 2 (1.6) 1 (0.8)
EHEC + STEC 0 (0) 1 (0.8)
EAEC + STEC 1 (0.8) 1 (0.8)
Total 10 (7.9) 8 (6.3)
aETEC Enterotoxigenic E. coli, ST heat stable toxin, STEC shiga toxin producing
E. coli, LT heat labile toxin, EPEC Enteropathogenic E. coli, EHEC
Enteroheamorrhagic E. coli, EAEC Enteroaggregative E. coli, EIEC Enteroinvasive
E. coli
Table 4 Frequency and age distribution of diarrhoeagenic Escherichia coli isolated from faecal samples of children with diarrhoeaa




Types of Diarrhoeagenic E. coli
EPEC (n = 7) EAEC (n = 10) ETEC (n = 20) STEC (n = 24) EHEC (n = 4)
0–6 25 8 (32) 2 (8) 0 (0) 1 (4) 5 (20) 0 (0)
7–12 57 32 (56.1) 4 (7) 4 (7) 11 (19.3) 10 (17.5) 3 (5.3)
13–24 33 23 (69.7) 1 (3) 5 (15.2) 8 (24.2) 8 (24.2) 1 (3)
25–60 11 2 (18.2) 0 (0) 1 (9.1) 0 (0) 1 (9.1) 0 (0)
aAge Age categories of children, EPEC Enteropathogenic E. coli, EAEC Enteroaggregative E. coli, ETEC Enterotoxigenic E. coli, STEC Shiga toxin producing E. coli, EHEC
Enteroheamorrhagic E. coli
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high rates of resistance to all the antibiotics except to cip-
rofloxacin (Table 7).
Multidrug resistance (i.e. resistance to three or more
different classes of antibiotics) was present in 98.4 % of
the DEC isolates (Table 8). The multi-resistance pattern
of the DEC isolates was compared with the non-DEC
isolates as shown in Table 5. Notably, 125 (98.4 %) of
DEC isolates were resistant to three or more antibiotics
in comparison to 736 (98.9 %) of the non-DEC isolates
showing that there was no significance difference be-
tween the two groups (χ2 = 0.115; p = 0.621).
Discussion
Diarrhoea remains one of the main causes of morbidity
and mortality in children worldwide and a large propor-
tion of bacterial gastroenteritis is caused by diarrhoea-
genic E. coli [1, 20]. In the present study, DEC was
isolated in 90 (35.7 %) samples from 126 mother-child
pairs, of which 45 (35.7 %) were from children with diar-
rhoea and 45 (35.7 %) were from their mothers. The
prevalence of DEC from children with diarrhoea in this
study is comparable to 37.1 % found in a previous con-
trolled study among children with diarrhoea in Ile-Ife
[21]. However, a limitation of the study is that children
without diarrhoea were not included as controls.
DEC was most commonly recovered from children be-
tween 7 and 24 months of age. Children below six months
of age may have been protected by maternal antibodies
from exclusive breastfeeding while older children may be
protected by their own acquired immunity following ex-
posure to the infectious agent earlier in life. The high
prevalence of DEC among children in the age group 7–24
months emphasizes the vulnerability during and following
weaning, at a time when children are still in close contact
with their mothers [22–25].
Multiple DEC categories were recovered from samples
from 8 (6.3 %) diarrheic children between 5 and 13 months
Table 5 Age distribution of mother and child pairs with
identical diarrhoeagenic E. coli pathotypesa
DEC Types Paired Age in months
Mother-child
N = 126 0–6 (%) 7–12 (%) 13–24 (%) 25–60 (%)
ETEC 5 (4.0) 0 (0) 4 (3.2) 1 (0.8) 0 (0)
EAEC 5 (4.0) 0 (0) 2 (1.6) 2 (1.6) 1 (0.8)
STEC 3 (2.4) 0 (0) 3 (2.4) 0 (0) 0 (0)
Total 13 (10.3) 0 (0) 9 (7.2) 3 (2.4) 1 (0.8)
a ETEC Enterotoxigenic E. coli, EAEC Enteroaggregative E. coli, STEC Shiga toxin
producing E. coli
Fig. 1 IS3 profiling gels of isolates with similar pathotypes of Escherichia coli from mother and child pairs. Lanes L: 1 kb ladder plus
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of age (Data not shown). Mixed infections are re-
ported to involve more dehydration when compared
with episodes caused by a single diarrhoeagenic E. coli
pathotype [26, 27].
STEC 42 (16.7 %) was the most prevalent DEC patho-
type isolated from both children with diarrhoea and
mothers. This observed high prevalence of STEC found
in this study is similar to the findings of Garcia [28] and
Alikhani [29] but it is in contrast to other studies that
reported very low prevalence in children with diarrhea
[11, 30, 31]. The detection of STEC in this study sug-
gests the possibility of community-wide risk of severe
STEC disease such as hemorrhagic colitis and hemolytic
uremic syndrome. It may also point to a high prevalence
of stx phages and therefore the potential for horizontal
transfer of virulence creating new pathogenic lineages or
hybrid strains. When STEC were found with another
pathotype, the second pathotype was most commonly
EPEC. Because EHEC carry eae and shiga toxin genes,
this combination might have been misinterpreted to rep-
resent EHEC had we used stool PCRs rather than the
isolation and identification methods we employed.
ETEC and EAEC have been reported as important
causes of childhood diarrhoea in West Africa [7, 32–35].
In this study, ETEC was detected in specimens from 20
(15.9 %) and EAEC 7.9 % of children. EAEC recovery
was lower than seen in some other Nigerian studies [11,
21]. The low recovery may be attributable to the use of a
DNA probe, CVD432 to detect EAEC in this study in
place of HEp-2 adherence assay which is the Gold
Standard for EAEC detection [21, 36]. The HEp-2 adher-
ence assay is currently not implementable in Nigeria be-
cause tissue culture is not available in existing
bacteriology labs. Recovery of identical pathotypes of
ETEC and EAEC from mother and child pairs suggests
the possible role of person-to-person transmission of in-
fection of these two DEC pathotypes although infection
from a common source can also not be ruled out.
Twenty-three (57.5 %) of the 40 ETEC strains identi-
fied in this study possess genes encoding the heat-labile
toxin (LT) and 16 (40 %) encode ST. In the recent
GEMS study and earlier research, ST-producing ETEC
have shown greater association with diarrhoea than al-
most all other enteropathogens at multiple developing
country sites [7]. It is therefore of concern that 11
(9.5 %) of mothers were found carrying this subcategory
of ETEC, which could potentially be transmitted to vul-
nerable children. Mothers also harbored all other DEC
categories recovered from the children with diarrhoea in
Table 6 Isolates from mother-child pairs demonstrating the same pathotype and similar IS3 profilesa
DEC Types Isolate No Resistance profiles fliC IS3
ETEC C114b TET SUL AMP NA G
M114e TET TRIM SUL AMP NAL CHLO NA G
C131d TET TRIM SUL AMP STREP NAL CHLO NA F
M131b TET TRIM SUL AMP STREP NAL NA F
C138c TET TRIM SUL AMP STREP S E
M138a TET TRIM SUL AMP CIP STREP NAL CHLO T E
EAEC C16b TET TRIM SUL AMP STREP CHLO R B
M16d TET TRIM SUL AMP STREP NAL CHLO R B
C271a TET TRIM SUL AMP STREP NAL CHLO P C
M271a TET TRIM SUL AMP STREP CHLO P C
STEC C72b TET TRIM SUL AMP STREP NAL Q D
M72a TET TRIM SUL AMP STREP Q D
aEAEC Enteroaggregative E. coli, ETEC Enterotoxigenic E. coli, STEC Shiga toxin producing E. coli, C child, M mother, TET Tetracycline, TRIM Trimethoprim, SUL
Sulphonamide, AMP Ampicillin, CIP Ciprofloxacin, STREP Streptomycin, NAL Nalidixic acid, CHLO Chloramphenicol, IS Insertion sequence, NA No amplicon
Fig. 2 RsaI RLFP profiles from DEC isolates with identical or similar
IS3 profiles. Lanes L: 1 kb ladder plus
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this study, except EIEC, adding to available data that
mothers and other adults may be reservoirs for enteric
pathogens associated with infantile diarrhea [37]. Of
note is the presence of identical DEC strains in three to
five mother-infant pairs. Interestingly, we did not see
identical strains among unpaired isolates, suggesting that
these strains are probably not clones that are disseminated
community-wide. Consequently, the data point to trans-
mission of some strains to children by their mothers, or
vice versa, or interfamilial infection from a common
source. Whichever of these scenarios is in play, interven-
tions that interfere with transmission within households
could prevent the dissemination of DEC, even if inde-
pendent acquisition of these pathogens by children is
more important.
Infantile diarrhoea should normally be managed without
antimicrobials. Antimicrobial drug therapy is however rec-
ommended when diarrhoea is invasive or persistent, and
concerns are increasing in studies reporting multiple anti-
microbial resistance among strains of pathogenic E. coli
[38–40]. Our data showed the presence of multidrug-
resistance in 123 of 125 (98.4 %) DEC isolates recovered
in this study. Recent reports point to similar trends among
enteric bacteria from Nigeria and neighboring countries
[41–46]. Our data suggest that, ciprofloxacin is an option
for treating persistent and invasive diarrheas in our local-
ity, but the finding that the fluoroquinolones are the only
tested antimicrobial class to which susceptibility is com-
mon is a critical concern.
The observed high prevalence of multidrug-resistance
in this and other studies is worrisome and reflective of
selection from heavy and indiscriminate use of common
antimicrobial agents [47]. While we did not test all anti-
microbial options, we did include a representative from
each broad antimicrobial class. In this study, resistance
to sulphonamide, tetracycline, trimethoprim, ampicillin
and streptomycin was most commonly seen. Only about
one in two isolates was found to be resistant to nalidixic
acid and chloramphenicol, while the lowest rate of re-
sistance was to ciprofloxacin. The relatively low rate of
resistance to ciprofloxacin 9 (7.2 %) observed might be
due to lower selective pressure due to its relative high
cost and its relatively recent introduction into Nigerian
[48]. Even then, this level of resistance is still worrisome,
as many strains are nalidixic acid resistant and therefore
already on the route to step-wise resistance to the fluor-
oquinolones. Moreover, fluroquinolone treatment failure
has been documented in nalidixic acid resistant strains
[49–51] and the fluoroquinolones are drugs of last resort
in the treatment of infectious diseases in this part of the
world.
Conclusion
In conclusion, diarrhoeagenic E. coli were found in
cases of childhood diarrhoea as well as in apparently
healthy mothers in Ile-Ife, Nigeria. STEC was the most
frequently detected pathotype but ETEC and EAEC
were most commonly found in both parties in mother-
child pairs. In children, diarrhoeagenic E. coli were most
Table 7 Antimicrobial resistance pattern of diarrhoeagenic E. coli isolatesa
Antimicrobial
agents
No of resistant DEC isolates (%) Non DEC (%) P-value
EPEC (N = 14) EAEC (N = 21) EHEC (N = 6) ETEC (N = 40) STEC (N = 42) EIEC (N = 2) Total (N = 125) N = 736
Tetracycline 14 (100) 21 (100) 6 (100) 37 (92.5) 39 (92.9) 2 (100) 119 (95.2) 683 (92.8) 0.326
Trimethoprim 11 (78.6) 21 (100) 5 (83.3) 36 (90) 38 (90.5) 2 (100) 113 (90.4) 617 (83.8) 0.059
Sulphonamide 12 (85.7) 21 (100) 6 (100) 37 (92.5) 40 (95.2) 2 (100) 118 (94.4) 689 (93.6) 0.738
Ampicillin 13 (92.9) 21 (100) 6 (100) 39 (97.5) 40 (95.2) 2 (100) 121 (96.8) 666 (90.5) 0.061
Ciprofloxacin 1 (7.1) 0 (0) 1 (16.7) 3 (7.3) 4 (9.5) 0 (0) 9 (7.2) 65 (8.8) 0.547
Streptomycin 12 (85.7) 21 (100) 6 (100) 35 (87.5) 39 (92.9) 2 (100) 115 (92) 706 (95.9) 0.090
Nalidixic acid 4 (28.6) 8 (38.1) 3 (50) 20 (50) 23 (54.8) 1 (50) 58 (46.4) 351 (47.7) 0.902
Chloramphenicol 16 (42.9) 12 (57.2) 1 (16.7) 13 (32.5) 25 (59.5) 1 (50) 58 (46.4) 356 (48.4) 0.538
aDEC diarrhoeagenic E. coli, EPEC Enteropathogenic E. coli, EAEC Enteroaggregative E. coli, EHEC Enteroheamorrhagic E. coli, ETEC Enterotoxigenic E. coli, STEC Shiga
toxin producing E. coli, EIEC Enteroinvasive E. coli, P probability
Table 8 Multi resistance of diarrhoeagenic E. coli and non
diarrhoeagenic E. coli to eight antibioticsa
No of tested antibiotics No of resistant isolates P-value
DEC N = 125 non-DEC N = 736
0 0 (0) 0 (0) -
1 0 (0) 3 (0.40) 1.000
2 2 (1.6) 12 (1.6) 0.980
3 10 (7.6) 9 (6.5) 0.583
4 7 (5.6) 60 (8.2) 0.325
5 30 (24) 200 (27.2) 0.458
6 46 (36.8) 207 (28.1) 0.063
7 28 (22.4) 183 (24.9) 0.554
8 6 (4.8) 38 (5.2) 0.865
≥3 123 (98.4) 728 (98.9) 0.621
aP probability, DEC diarrhoeagenic Escherichia coli, non-DEC non- diarrhoeagenic
Escherichia coli
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commonly detected in children aged 7 to 24 months.
There was a very high rate of antibacterial resistance in
diarrhoeagenic Escherichia coli to antibiotics that are
commonly employed to treat infections with the excep-
tion of ciprofloxacin. This study highlights the import-
ance E. coli pathotypes as agents of diarrhoea and
points to the possibility of person-to-person transmis-
sion in their spread. Because DEC pathogens were
isolated in apparently healthy mothers, the data suggest
that household members such as mothers can serve as
asymptomatic reservoirs for strains that are potentially
pathogenic in young children. In a small number of
instances, apparently identical DEC isolates were recov-
ered from mother-child pairs. Both these findings points
to a need for improved sanitation and hand washing inter-
ventions in the home as well as the development of
vaccines that can protect weaned children from the most
common pathotypes. Furthermore, antimicrobial steward-
ship programs that impact community use of these drugs
are needed to contain antimicrobial resistance.
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